Efficacy Of Loralatinib In Combination With Alectinib In Patients With Anaplastic Kinase-Positive Small Cell Lung Cancer With Moderate Lung Disease: A Case Report. Clinical and Medical Case Reports [Internet]. 2022 Jan. 27 [cited 2025 Jan. 23];2(01):34-7. Available from: https://currentopinion.info/index.php/cmcr/article/view/77